Abstract
The U.S. Food and Drug Administration is charged with the responsibility of assuring safety and efficacy of marketed drugs and safe conditions for clinical investigation of drugs.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1972 Springer Science+Business Media New York
About this chapter
Cite this chapter
Finkel, M.J. (1972). Antilipemic Drugs and the Position of the FDA. In: Holmes, W.L., Paoletti, R., Kritchevsky, D. (eds) Pharmacological Control of Lipid Metabolism. Advances in Experimental Medicine and Biology, vol 26. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-7547-0_22
Download citation
DOI: https://doi.org/10.1007/978-1-4684-7547-0_22
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-7549-4
Online ISBN: 978-1-4684-7547-0
eBook Packages: Springer Book Archive